arrow
S

Sheryl L. Windsor

massachusetts general hospital
H指数:20
被引数:3,547

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Orthostatic Pulse Pressure, A Novel Indicator of Preload Insufficiency, May Predict Clinical Response to SGLT2 Inhibition in HFpEF: Findings from the PRESERVED-HF Trial

体位性脉压,一种预负荷不足的新型指标,可能预测HFpEF患者对SGLT2抑制剂的临床反应:PRESERVED-HF试验结果

2024-11-120
PRE
Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction
2024-10-180
PRE
Effect of Dapagliflozin on 6-Minute Walk Distance in Heart Failure With Preserved Ejection Fraction: PRESERVED-HF

达格列净对射血分数保留的心力衰竭患者6分钟步行距离的影响:PRESERVED-HF

2023-11-016
OAAI
Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF Trials
2023-07-0117
OAAI
Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF
2022-09-1347
OA
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
2021-10-28373
OAAI
Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the DEFINE-HF trial
2021-03-2616
OAAI
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction The DEFINE-HF Trial
2019-10-29308
OAAI